UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microcirculation and tolerability following i.v. infusion of PGE 1 and iloprost: a randomized cross-over study in patients with critical limb ischemia

Prostaglandins, leukotrienes and essential fatty acids, 2004, Vol.70 (6), p.503-509

2004

Volltextzugriff (PDF)

Treadmill testing for evaluation of claudication: Comparison of constant-load and graded-exercise tests

European journal of vascular and endovascular surgery, 1997-10, Vol.14 (4), p.238-243

1997

Volltextzugriff (PDF)

Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1994-03, Vol.45 (1), p.27

1994

Volltextzugriff (PDF)

Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease

The Lancet (British edition), 1990-03, Vol.335 (8690), p.627-628

1990

Volltextzugriff (PDF)

PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion technique

Prostaglandins, leukotrienes and essential fatty acids, 1997-04, Vol.56 (4), p.325-330

1997

Volltextzugriff (PDF)

Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication

VASA, 1997-05, Vol.26 (2), p.122

1997

Volltextzugriff (PDF)

Prostaglandin E1 increases binding of 123I-low-density lipoprotein to the human liver in vivo

European journal of clinical pharmacology, 1996, Vol.49 (6), p.515-520

1996

Volltextzugriff (PDF)

Interaction between prostaglandin E1 and nitric oxide (NO)

Thrombosis research, 1991-05, Vol.62 (4), p.299-304

1991

Volltextzugriff (PDF)

Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication : Results of a multicenter placebo-controlled double-blind trial

Journal of vascular surgery, 1997-03, Vol.25 (3), p.537-544

1997

Volltextzugriff (PDF)

On the metabolism of prostaglandin E1 administered intravenously to human volunteers

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1991-09, Vol.42 (3), p.327

1991

Volltextzugriff (PDF)

125I-liprotein (a) in experimental atherosclerosis: Influence of isradipine and ASA

Nuclear medicine communications, 1995-04, Vol.16 (4), p.242-242

1995

Volltextzugriff (PDF)

Efficacy of a new prostaglandin E 1 regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial

Journal of vascular surgery, 1997, Vol.25 (3), p.537-544

1997

Volltextzugriff (PDF)

Improvement of Peripheral and Cardiopulmonary Performance After a Short-Term Exercise Program with Additive Prostaglandin E1

Angiology, 2001-06, Vol.52 (6), p.381-391

2001

Volltextzugriff (PDF)

Beneficial effect of long-term PGE1-treatment in left ventricular heart failure

Prostaglandins, leukotrienes and essential fatty acids, 1989-12, Vol.38 (3), p.177-180

1989

Volltextzugriff (PDF)

Influence of prostaglandin E1 on in vitro oxidation of human low density lipoproteins

Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Vol.23, p.409

1995

Volltextzugriff (PDF)

Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia

Prostaglandins, leukotrienes and essential fatty acids, 2004-06, Vol.70 (6), p.503-509

2004

Volltextzugriff (PDF)

7. Potential of mildly oxidized LP(a) for studying atherosclerotic vascular lesions: experimental and preliminary clinical background

Nuclear medicine communications, 2001-10, Vol.22 (10), p.1154

2001

Volltextzugriff (PDF)

Synergism between PGE1-metabolites (13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation

Prostaglandins, leukotrienes and essential fatty acids, 1992-03, Vol.45 (3), p.207-210

1992

Volltextzugriff (PDF)

Long-term improvement in left ventricular ejection fraction during continuous PGE1-therapy in a patient with congestive cardiomyopathy

Postgraduate medical journal, 1988-12, Vol.64 (758), p.975-975

1988

Volltextzugriff (PDF)

Effects of microencapsulated vs. enteric-coated acetylsalicylic acid on gastric and duodenal mucosa: an endoscopic study

Journal of clinical gastroenterology, 1988-06, Vol.10 (3), p.269-272

1988

Volltextzugriff (PDF)

PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wall

VASA, 1995, Vol.24 (4), p.333

1995

Volltextzugriff (PDF)

Urokinase quality: analysis of different preparations

Thrombosis and haemostasis, 1985-01, Vol.53 (2), p.245-248

1985

Volltextzugriff (PDF)

Randomized Reliability Study Evaluating Constant-load and Graded-exercise Treadmill Test for Intermittent Claudication

Angiology, 1999-03, Vol.50 (3), p.193-200

1999

Volltextzugriff (PDF)

Prostaglandin E1 in therapy of peripheral arterial occlusive disease

Wiener Klinische Wochenschrift, 1991, Vol.103 (18), p.558-565

1991

Volltextzugriff (PDF)

34. Scintigraphic imaging of atherosclerotic lesions with oxidised Lp(a)? Experimental background

Nuclear medicine communications, 1999-10, Vol.20 (10), p.964

1999

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(56)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Male
(28)
Alprostadil - Pharmacology
(19)
Female
(19)
Biological And Medical Sciences
(17)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Alprostadil - Administration & Dosage
(15)
Middle Aged
(14)
Animals
(12)
Infusions, Intravenous
(12)
Medical Sciences
(12)
Aged
(11)
Pharmacology. Drug Treatments
(11)
Adult
(10)
Rabbits
(8)
Alprostadil - Analogs & Derivatives
(7)
Blood Platelets - Drug Effects
(7)
Cardiovascular System
(7)
Alprostadil - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microcirculation and tolerability following i.v. infusion of PGE 1 and iloprost: a randomized cross-over study in patients with critical limb ischemia

Treadmill testing for evaluation of claudication: Comparison of constant-load and graded-exercise tests

Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies

Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease

PGE1-induced arterial thromboresistance is a vascular property as identified by cross-perfusion technique

Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication

Prostaglandin E1 increases binding of 123I-low-density lipoprotein to the human liver in vivo

Interaction between prostaglandin E1 and nitric oxide (NO)

Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication : Results of a multicenter placebo-controlled double-blind trial

On the metabolism of prostaglandin E1 administered intravenously to human volunteers

125I-liprotein (a) in experimental atherosclerosis: Influence of isradipine and ASA

Efficacy of a new prostaglandin E 1 regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial

Improvement of Peripheral and Cardiopulmonary Performance After a Short-Term Exercise Program with Additive Prostaglandin E1

Beneficial effect of long-term PGE1-treatment in left ventricular heart failure

Influence of prostaglandin E1 on in vitro oxidation of human low density lipoproteins

Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia

7. Potential of mildly oxidized LP(a) for studying atherosclerotic vascular lesions: experimental and preliminary clinical background

Synergism between PGE1-metabolites (13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation

Long-term improvement in left ventricular ejection fraction during continuous PGE1-therapy in a patient with congestive cardiomyopathy

Effects of microencapsulated vs. enteric-coated acetylsalicylic acid on gastric and duodenal mucosa: an endoscopic study

PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wall

Urokinase quality: analysis of different preparations

Randomized Reliability Study Evaluating Constant-load and Graded-exercise Treadmill Test for Intermittent Claudication

Prostaglandin E1 in therapy of peripheral arterial occlusive disease

34. Scintigraphic imaging of atherosclerotic lesions with oxidised Lp(a)? Experimental background

Suchergebnisse filtern